Next week, Nina Woodworth and Malin Hultqvist Davidsson will be heading to San Diego for BIO International.
For us, BIO offers an opportunity to reconnect with partners, meet new people, and gain perspective on where our industry is heading. I’m looking forward to discussing new science, emerging therapeutic approaches, and the opportunities and challenges companies face as they advance their programs.
At Redoxis we spend our days working alongside biotech and pharma companies to answer critical preclinical questions—from understanding mechanisms of action to evaluating efficacy and generating the data needed to make informed development decisions. Working across a broad range of modalities and immune-mediated diseases gives us a unique perspective on both the scientific advances and practical challenges shaping drug development today.
If you’ll be in San Diego and would like to discuss immunology, inflammation or preclinical development, feel free to reach out.